2024 ICE-HBV Annual Symposium
The International Coalition to Eliminate HBV (ICE-HBV) invites you to its annual symposium at the International HBV Meeting. This event is aimed at scientists, clinicians and industry professionals. For details, please contact info@ice-hbv.org.
Registration is required. The cost is $50 USD (no sales tax). To register for the Symposium ONLY, please click here
Sunday, Sept. 15, 2024, from 9:30 a.m. to 12:30 p.m. CDT
Interferons for Hepatitis B and D: their continuing contributions to cure strategies
9:30 a.m. Welcome/Opening Remarks: Massimo Levrero, Cancer Research Center of Lyon (CRCL) and Lyon Hepatology Institute (IHU LYON), Lyon France; and Nina Le Bert, Duke-NUS Medical School, Singapore
9:35 a.m. The Clinical Perspective on Interferon Therapy for Hepatitis B and D – Jordan Feld (on-site), University of Toronto, Canada
9:55 a.m. Antiviral Activities of Class I and III interferons: A Virological Perspective – Barbara Testoni (on-site), Cancer Research Center of Lyon (CRCL) and Lyon Hepatology Institute (IHU LYON), Lyon, France
10:15 a.m. Immuno-Modulatory Activities of Class I/III IFNs in Hepatitis: Impact on Innate and Adaptive Responses – Adam Gehring (on-site), Toronto Centre for Liver Disease, Canada
10:35 a.m. Innovative Approaches: Pre-Clinical Development of a Bi-Specific (CD40-IFNa) Fusion Protein for HBV and HDV – Kara Carter (on-site), Evotec/Avifa, France
10:55 a.m. Coffee Break
11:15 a.m. Partnering with Interferons to boost functional cure: ongoing clinical trials – Florian Lempp, Vir Biotechnology, and Simon Fletcher, Gilead Sciences
12 p.m. Panel Discussion (all speakers)
12:25 p.m. Closing Remarks